Skip to main content
SpringerLink
Log in

Dear SIRS, the concept of “alarmins” makes a lot of sense!

  • Editorial
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bone RC (1991) Let's agree on terminology: definitions of sepsis. Crit Care Med 19:973–976

    Article  PubMed  CAS  Google Scholar 

  2. Bone RC (1992) Toward an epidemiology and natural history of SIRS (systemic inflammatory response syndrome). JAMA 268:3452–3455

    Article  PubMed  CAS  Google Scholar 

  3. Brun-Buisson C (2000) The epidemiology of the systemic inflammatory response. Intensive Care Med [Suppl] 26(1):S64–S74

    Article  Google Scholar 

  4. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117–123

    Article  PubMed  CAS  Google Scholar 

  5. Bone RC, Sibbald WJ, Sprung CL (1992) The ACCP-SCCM Consensus Conference on Sepsis and Organ Failure. Chest 101:1481–1483

    Article  PubMed  CAS  Google Scholar 

  6. Marshall J (1997) Both the disposition and the means of cure: “Severe SIRS,” “sterile shock,” and the ongoing challenge of description. Crit Care Med 25:1765–1766

    Article  PubMed  CAS  Google Scholar 

  7. Moore FA, Moore EE (1995) Evolving concepts in the pathogenesis of postinjury multiple organ failure. Surg Clin North Am 75:257–277

    PubMed  CAS  Google Scholar 

  8. Opal SM (1998) The uncertain value of the definition for SIRS. Systemic inflammatory response syndrome. Chest 113:1442–1443

    Article  PubMed  CAS  Google Scholar 

  9. Vincent JL (1997) Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med 25:372–374

    Article  PubMed  CAS  Google Scholar 

  10. Dugernier TL, Laterre PF, Wittebole X, Roeseler J, Latinne D, Reynaert MS, Pugin J (2003) Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 168:148–157

    Article  PubMed  Google Scholar 

  11. Pugin J, Ricou B, Steinberg KP, Suter PM, Martin TR (1996) Proinflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am J Respir Crit Care Med 153:1850–1856

    PubMed  CAS  Google Scholar 

  12. Pugin J, Verghese G, Widmer MC, Matthay MA (1999) The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit Care Med 27:304–312

    Article  PubMed  CAS  Google Scholar 

  13. Goldie AS, Fearon KC, Ross JA, Barclay GR, Jackson RE, Grant IS, Ramsay G, Blyth AS, Howie JC (1995) Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA 274:172–177

    Article  PubMed  CAS  Google Scholar 

  14. Fumeaux T, Pugin J (2002) Role of interleukin-10 in the intracellular sequestration of human leukocyte antigen-DR in monocytes during septic shock. Am J Respir Crit Care Med 166:1475–1482

    Article  PubMed  Google Scholar 

  15. Munford RS, Pugin J (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163:316–321

    PubMed  CAS  Google Scholar 

  16. Singer M (2007) System interactions. Novartis Found Symp 280:252–262

    PubMed  CAS  Google Scholar 

  17. Pugin J (2007) Immunostimulation is a rational therapeutic strategy in sepsis. Novartis Found Symp 280:21–27

    PubMed  CAS  Google Scholar 

  18. Janeway CA Jr (1992) The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 13:11–16

    Article  PubMed  CAS  Google Scholar 

  19. Matzinger P (1994) Tolerance, danger, and the extended family. Annu Rev Immunol 12:991–1045

    PubMed  CAS  Google Scholar 

  20. Matzinger P (2002) The danger model: a renewed sense of self. Science 296:301–305

    Article  PubMed  CAS  Google Scholar 

  21. Matzinger P (2002) An innate sense of danger. Ann N Y Acad Sci 961:341–342

    PubMed  Google Scholar 

  22. Fraser CK, Diener KR, Brown MP, Hayball JD (2007) Improving vaccines by incorporating immunological coadjuvants. Expert Rev Vaccines 6:559–578

    Article  PubMed  CAS  Google Scholar 

  23. Adib-Conquy M, Cavaillon JM (2007) Stress molecules in sepsis and systemic inflammatory response syndrome. FEBS Lett 581:3723–3733

    Article  PubMed  CAS  Google Scholar 

  24. Bianchi ME (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 81:1–5

    Article  PubMed  CAS  Google Scholar 

  25. Oppenheim JJ, Yang D (2005) Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 17:359–365

    Article  PubMed  CAS  Google Scholar 

  26. Harris HE, Raucci A (2006) Alarmin (g) news about danger: workshop on innate danger signals and HMGB1. EMBO Rep 7:774–778

    PubMed  CAS  Google Scholar 

  27. Raucci A, Palumbo R, Bianchi ME (2007) HMGB1: a signal of necrosis. Autoimmunity 40:285–289

    Article  PubMed  CAS  Google Scholar 

  28. El Mezayen R, El Gazzar M, Seeds MC, McCall CE, Dreskin SC, Nicolls MR (2007) Endogenous signals released from necrotic cells augment inflammatory responses to bacterial endotoxin. Immunol Lett 111:36–44

    Article  PubMed  CAS  Google Scholar 

  29. Miyake K (2007) Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin Immunol 19:3–10

    Article  PubMed  CAS  Google Scholar 

  30. Yang H, Wang H, Tracey KJ (2001) HMG-1 rediscovered as a cytokine. Shock 15:247–253

    Article  PubMed  CAS  Google Scholar 

  31. Yu M, Wang H, Ding A, Golenbock DT, Latz E, Czura CJ, Fenton MJ, Tracey KJ, Yang H (2006) HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26:174–179

    Article  PubMed  CAS  Google Scholar 

  32. Kokkola R, Andersson A, Mullins G, Ostberg T, Treutiger CJ, Arnold B, Nawroth P, Andersson U, Harris RA, Harris HE (2005) RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 61:1–9

    Article  PubMed  CAS  Google Scholar 

  33. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248–251

    Article  PubMed  CAS  Google Scholar 

  34. Mantell LL, Parrish WR, Ulloa L (2006) Hmgb-1 as a therapeutic target for infectious and inflammatory disorders. Shock 25:4–11

    Article  PubMed  CAS  Google Scholar 

  35. Gibot S, Massin F, Cravoisy A, Barraud D, Nace L, Levy B, Bollaert PE (2007) High-mobility group box 1 protein plasma concentrations during septic shock. Intensive Care Med 33:1347–1353

    Article  PubMed  CAS  Google Scholar 

  36. Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, Vodovotz Y, Billiar TR (2007) Systemic inflammation and remote organ injury following trauma require HMGB1. Am J Physiol Regul Integr Comp Physiol (epub ahead of print 25 July)

  37. Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Nakajima T, Kuroda Y (2006) Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol 12:7666–7670

    PubMed  CAS  Google Scholar 

  38. Yang R, Harada T, Mollen KP, Prince JM, Levy RM, Englert JA, Gallowitsch-Puerta M, Yang L, Yang H, Tracey KJ, Harbrecht BG, Billiar TR, Fink MP (2006) Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 12:105–114

    PubMed  CAS  Google Scholar 

  39. Esmon CT (2004) Interactions between the innate immune and blood coagulation systems. Trends Immunol 25:536–542

    Article  PubMed  CAS  Google Scholar 

  40. Hagiwara S, Iwasaka H, Matsumoto S, Noguchi T (2007) High dose antithrombin III inhibits HMGB1 and improves endotoxin-induced acute lung injury in rats. Intensive Care Med DOI 10.007/s00134-007-0887-5

  41. Wiedermann C J, Romisch J (2002) The anti-inflammatory actions of antithrombin-a review. Acta Med Austriaca 29:89–92

    Article  PubMed  Google Scholar 

  42. Kienast J, Juers M, Wiedermann CJ, Hoffmann JN, Ostermann H, Strauss R, Keinecke HO, Warren BL, Opal SM (2006) Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. J Thromb Haemost 4:90–97

    Article  PubMed  CAS  Google Scholar 

  43. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM (2001) Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 286:1869–1878

    Article  PubMed  CAS  Google Scholar 

  44. Ito T, Kawahara K, Nakamura T, Yamada S, Nakamura T, Abeyama K, Hashiguchi T, Maruyama I (2007) High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost 5:109–116

    Article  PubMed  CAS  Google Scholar 

  45. Wang H, Li W, Goldstein R, Tracey KJ, Sama AE (2007) HMGB1 as a potential therapeutic target. Novartis Found Symp 280:73–85

    Article  PubMed  CAS  Google Scholar 

  46. Izuishi K, Tsung A, Jeyabalan G, Critchlow ND, Li J, Tracey KJ, Demarco RA, Lotze MT, Fink MP, Geller DA, Billiar TR (2006) Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol 176:7154–7158

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, University Hospital of Geneva, 1211, Geneva 14, Switzerland

    Jérôme Pugin

Authors
  1. Jérôme Pugin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jérôme Pugin.

Additional information

This editorial refers to the article available at: http://dx.doi.org/10.1007/s00134-007-0887-5.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pugin, J. Dear SIRS, the concept of “alarmins” makes a lot of sense!. Intensive Care Med 34, 218–221 (2008). https://doi.org/10.1007/s00134-007-0888-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-007-0888-4

Search

Navigation